Tag:

companion diagnostic

Latest Headlines

Latest Headlines

Abbott strikes companion Dx deal with AstraZeneca for severe asthma therapy

Abbott is teaming up with biotech heavyweight AstraZeneca to develop companion diagnostic tests for the company's investigational asthma therapy, a potentially fruitful alliance as Abbott rides the tailwinds of promising diagnostic sales.

Abbott strikes companion Dx deal with AstraZeneca for severe asthma therapy

Abbott is teaming up with biotech heavyweight AstraZeneca to develop companion diagnostic tests for the company's investigational asthma therapy, a potentially fruitful alliance as Abbott rides the tailwinds of promising diagnostic sales.

FDA approves Roche's cancer diagnostic as a guide to use of Amgen, Lilly meds

The FDA approved Roche's diagnostic for the KRAS mutation in metastatic colorectal cancer patients, saying it needed to identify those without the mutation, for whom treatment with Eli Lilly's Erbitux or Amgen's Vectibix may be effective.

FDA approves Roche's cancer diagnostic as a guide to use of Amgen, Lilly meds

The FDA approved Roche's diagnostic for the KRAS mutation in metastatic colorectal cancer patients, saying it needed to identify those without the mutation, for whom treatment with Eli Lilly's Erbitux or Amgen's Vectibix may be effective.

Roche, undaunted by reimbursement cutbacks, sees no need for Dx price reductions

Execs with Roche's diagnostics arm remain bullish about U.S. growth prospects even as reimbursement cuts place new pressures on the sector overall. An executive with the company anticipates booming demand to the point that price reductions aren't on the table.

Roche, undaunted by reimbursement cutbacks, sees no need for Dx price reductions

Execs with Roche's diagnostics arm remain bullish about U.S. growth prospects even as reimbursement cuts place new pressures on the sector overall. An executive with the company anticipates booming demand to the point that price reductions aren't on the table.

Verastem gears up for companion Dx mesothelioma treatment trial

Verastem's quest to develop drugs that block cell signaling pathways that cancer stem cells need to survive hits a major milestone in mid-2013, when it launches a 350-patient clinical trial of a potential companion biomarker test for its investigative mesothelioma drug treatment.

Verastem gears up for companion Dx mesothelioma treatment trial

Verastem's quest to develop drugs that block cell signaling pathways that cancer stem cells need to survive hits a major milestone in mid-2013, when it launches a 350-patient clinical trial of a potential companion biomarker test for its investigative mesothelioma drug treatment.

Qiagen seeks FDA sign-off for lung cancer companion Dx

Qiagen disclosed it is seeking the FDA's blessing for a lung cancer-drug companion diagnostic, a test designed to screen patients for whom Boehringer Ingelheim's investigational treatment might work.

Ventana to work with Seattle Genetics, Millennium on companion Dx

The companion diagnostic trend continues--and Ventana Medical Systems is involved yet again. This morning, Seattle Genetics and Takeda's Millennium unit announced that they are working with the Roche company on a companion diagnostic test for use in a study involving Adcetris.